CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+66.99%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$485M
AUM Growth
+$485M
Cap. Flow
+$108M
Cap. Flow %
22.25%
Top 10 Hldgs %
56.78%
Holding
69
New
16
Increased
8
Reduced
9
Closed
5

Top Buys

1
PBYI icon
Puma Biotechnology
PBYI
$71.6M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
$16.8M
3
KERX
Keryx Biopharmaceuticals Inc
KERX
$13.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
$8.62M
5
TPST icon
Tempest Therapeutics
TPST
$8.57M

Top Sells

1
QCOR
QUESTCOR PHARMA INC
QCOR
$18.5M
2
CELG
Celgene Corp
CELG
$17.2M
3
OMER icon
Omeros
OMER
$7.31M
4
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$7.2M
5
MRK icon
Merck
MRK
$5.79M

Sector Composition

1 Healthcare 79.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NKTR icon
26
Nektar Therapeutics
NKTR
$543M
$5.43M 1.12%
+30,000
New +$5.43M
SGMO icon
27
Sangamo Therapeutics
SGMO
$161M
$5.39M 1.11%
500,000
– –
CBPO
28
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$5.13M 1.05%
95,000
-5,000
-5% -$270K
EGRX
29
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5.06M 1.04%
400,000
– –
PTLA
30
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.06M 1.04%
200,000
– –
QTNT
31
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4.72M 0.97%
12,500
– –
SRNE
32
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4.52M 0.93%
1,000,000
– –
ALKS icon
33
Alkermes
ALKS
$4.95B
$4.29M 0.88%
100,000
– –
ALNY icon
34
Alnylam Pharmaceuticals
ALNY
$58.6B
$3.91M 0.8%
50,000
– –
ARAV
35
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.8M 0.78%
33,333
– –
RMTI icon
36
Rockwell Medical
RMTI
$59.6M
$3.66M 0.75%
36,364
– –
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
$3.57M 0.73%
1,000,000
– –
IMDZ
38
DELISTED
Immune Design Corp.
IMDZ
$3.53M 0.73%
+200,000
New +$3.53M
NSTG
39
DELISTED
NanoString Technologies, Inc.
NSTG
$3.28M 0.68%
300,000
– –
CBIO
40
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$3.28M 0.67%
4,723
– –
KIN
41
DELISTED
Kindred Biosciences, Inc.
KIN
$3.24M 0.67%
350,000
+250,000
+250% +$2.31M
CLVS
42
DELISTED
Clovis Oncology, Inc.
CLVS
$3.18M 0.65%
70,000
– –
KITE
43
DELISTED
Kite Pharma, Inc.
KITE
$2.85M 0.59%
+100,000
New +$2.85M
GNVC
44
DELISTED
GenVec, Inc.
GNVC
$2.77M 0.57%
132,930
– –
ASPX
45
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$2.57M 0.53%
100,000
– –
GALT icon
46
Galectin Therapeutics
GALT
$288M
$2.27M 0.47%
450,400
-349,600
-44% -$1.76M
ADVM icon
47
Adverum Biotechnologies
ADVM
$68.2M
$2.22M 0.46%
+6,500
New +$2.22M
SCTL
48
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2.07M 0.43%
780,500
+223,000
+40% +$592K
AGEN
49
Agenus
AGEN
$136M
$2.02M 0.42%
33,118
-12,737
-28% -$778K
NGNE icon
50
Neurogene
NGNE
$284M
$2M 0.41%
15,000
– –
1
2
3